Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study

BACKGROUND & AIMS: Liver stiffness measurement (LSM) using vibration-controlled transient elastography (VCTE) is a noninvasive tool for assessing severity in primary biliary cholangitis (PBC). While the baseline prognostic value of LSM has been recognized, the clinical significance of longitudinal LSM changes remains underexplored, especially in Asian populations. This study evaluated both baseline and dynamic LSM measurements for predicting adverse outcomes in PBC. METHODS: This multicenter retrospective cohort study analyzed 454 Japanese patients with PBC who underwent VCTE at seven tertiary centers. The primary outcome was a composite of liver-related events, liver transplantation, and all-cause mortality. Kaplan-Meier testing, Cox proportional hazards models, and receiver operating characteristic (ROC) curve analysis were adopted to assess the prognostic performance of baseline LSM and annual LSM changes (ΔLSM/year). RESULTS: During a median follow-up of 4.2 years, 14 patients (3.0%) either died or underwent liver transplantation, and 42 patients (9.3%) experienced liver-related events. Baseline LSM ≥ 8.0 kPa was independently associated with all-cause mortality (hazard ratio 4.79, 95% confidence interval 1.10-20.92). Patients with ΔLSM/year ≥ 2.1 kPa had significantly lower 5-year survival and event-free survival compared with those exhibiting slower disease progression. The area under the ROC curve values of baseline LSM for predicting liver-related events was high at 0.803. Furthermore, LSM ≥ 8.0 kPa stratifies prognosis even in patients who achieved normalization of alkaline phosphatase levels following treatment. CONCLUSIONS: Both baseline and longitudinal increases in LSM predict adverse outcomes in PBC and may signal the need for closer monitoring or early therapeutic intervention. TRAIL REGISTRATION: Approval number 5313.

Authors

Institutions

Publication Details

Journal
Hepatology Research
Published
2026-06-18
DOI
https://doi.org/10.1111/hepr.70223
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study

Masaaki Takamura, Kazumichi Abe, Shun‐ichi Wakabayashi, Takanobu Iwadare et al.
Hepatology Research
Liver Diseases and Immunity
article

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study

Masaaki Takamura, Kazumichi Abe, Shun‐ichi Wakabayashi, Takanobu Iwadare, Tadashi Namisaki, Yūki Yamashita, Taiki Okumura, Takeji Umemura, Yuki Kugiyama, Tomoo Yamazaki, Satoru Joshita, Masanori Abe, Atsumasa Komori, Hiroyuki Kobayashi, K. Fujita, Takefumi Kimura, Atsushi Tanaka, Akinobu Takaki
article en

Abstract

BACKGROUND & AIMS: Liver stiffness measurement (LSM) using vibration-controlled transient elastography (VCTE) is a noninvasive tool for assessing severity in primary biliary cholangitis (PBC). While the baseline prognostic value of LSM has been recognized, the clinical significance of longitudinal LSM changes remains underexplored, especially in Asian populations. This study evaluated both baseline and dynamic LSM measurements for predicting adverse outcomes in PBC. METHODS: This multicenter retrospective cohort study analyzed 454 Japanese patients with PBC who underwent VCTE at seven tertiary centers. The primary outcome was a composite of liver-related events, liver transplantation, and all-cause mortality. Kaplan-Meier testing, Cox proportional hazards models, and receiver operating characteristic (ROC) curve analysis were adopted to assess the prognostic performance of baseline LSM and annual LSM changes (ΔLSM/year). RESULTS: During a median follow-up of 4.2 years, 14 patients (3.0%) either died or underwent liver transplantation, and 42 patients (9.3%) experienced liver-related events. Baseline LSM ≥ 8.0 kPa was independently associated with all-cause mortality (hazard ratio 4.79, 95% confidence interval 1.10-20.92). Patients with ΔLSM/year ≥ 2.1 kPa had significantly lower 5-year survival and event-free survival compared with those exhibiting slower disease progression. The area under the ROC curve values of baseline LSM for predicting liver-related events was high at 0.803. Furthermore, LSM ≥ 8.0 kPa stratifies prognosis even in patients who achieved normalization of alkaline phosphatase levels following treatment. CONCLUSIONS: Both baseline and longitudinal increases in LSM predict adverse outcomes in PBC and may signal the need for closer monitoring or early therapeutic intervention. TRAIL REGISTRATION: Approval number 5313.

Hepatology Research
Fukushima Medical University (JP), Shinshu University (JP), Okayama University (JP), Niigata City General Hospital (JP), Nagasaki Medical Center (JP), Shinshu University Hospital (JP), Ehime University (JP), Nara Medical University (JP), Teikyo University (JP)
Good health and well-being
Openalex Percentile: Top 8%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.